ATNM
Actinium Pharmaceuticals Inc
1.20$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -647.6% | – | – | |
| – | +41.0% | +45.0% | -27.8% | -9.3% | +728.2% | +6.4% | +17.2% | +33.4% | +13.0% | +2.7% | +1.2% | |
| – | +12.4% | -39.1% | -18.7% | -48.5% | -28.0% | -3.1% | +35.1% | +65.0% | +37.5% | +37.7% | +73.7% | |
| – | -48.3% | -45.6% | +80.5% | -43.6% | -28.0% | -3.1% | +35.1% | +65.0% | – | – | – | |
| – | -145.3% | – | +6.8% | -31.6% | -203.5% | – | – | +2,158.4% | -108.3% | – | – | |
| – | -68.5% | +25.5% | -58.7% | +288.4% | -33.5% | +296.0% | -47.4% | +175.2% | -58.2% | -92.8% | +845.5% | |
| – | -74.4% | +129.8% | +246.9% | -74.8% | -33.5% | +296.0% | -47.4% | +175.2% | -58.2% | -92.8% | +845.5% | |
| – | – | – | – | – | – | -21.2% | – | – | – | – | – | |
| – | +145.0% | -57.6% | +17.3% | -9.7% | -100.0% | -21.2% | +3,530,500.0% | – | – | – | – | |
| – | +75.2% | -6.3% | +21.2% | – | -1,650.2% | +84.6% | -81.5% | -42.4% | -91.8% | +125.0% | +11.1% | |
| – | +138.9% | -58.0% | +19.3% | -9.7% | +0.8% | +345.1% | -53.8% | -34.4% | -35.7% | +97.2% | -100.7% | |
| – | +1,513.8% | -127.1% | – | – | – | – | -73.8% | +120.7% | -204.0% | – | – | |
| – | – | – | – | – | – | – | – | – | -673.7% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.